Intravesical Therapy for Bladder Cancer
Immunotherapy helps the body’s own immune system attack the cancer cells. BCG is the most common intravesical immunotherapy for treating early-stage bladder cancer. BCG is a vaccine made from a germ that's related to the one that causes tuberculosis (TB), but it doesn’t cause serious disease.
BCG Treatment: What It Is, Procedure & Side Effects - Cleveland Clinic
Bacillus Calmette-Guerin (BCG) treatment is a type of intravesical (in your bladder) immunotherapy. This liquid drug is made from a strain of Mycobacterium bovis — the same bacterium used to create the tuberculosis vaccine.
Update on intravesical agents for non-muscle-invasive bladder …
2024年11月28日 · Intravesical bacillus Calmette–Guerin immunotherapy Dose & strain After bacillus Calmette–Guerin (BCG) was isolated and described as an antituberculosis vaccine, in vivo and in vitro studies demonstrated significant antitumor effects against several malignant cell lines [ 10 – 14 ].
Immunotherapy for Bladder Cancer - American Cancer Society
Intravesical immunotherapy. These treatments are put directly into the bladder. They are used mainly for early-stage bladder cancers that haven’t grown deeply into the wall of the bladder. Bacillus Calmette-Guerin (BCG) is made from a type of bacteria related to the one that causes tuberculosis. While it doesn’t usually make a person sick ...
BCG Treatment: What It Is, Procedure, Side Effects - Healthline
2023年5月22日 · Bacillus Calmette-Guerin (BCG) is the main intravesical immunotherapy for early-stage bladder cancer. It can help the immune system get rid of cancer cells in the bladder but may cause side...
Intravesical Therapy for Bladder Cancer - NYU Langone Health
Intravesical medications exit the body through urination. We lead clinical trials that offer innovative treatment options, including immunotherapy, vaccines, and targeted therapies for people who have high-risk noninvasive bladder cancer.
Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer
Bacillus Calmette-Guérin (buh-SIH-lus KAL-met-gay-RIN) therapy is a type of immunotherapy that treats bladder tumors. It’s the most common kind of intravesical immunotherapy used to treat early-stage bladder cancer.
BCG Immunotherapy: Uses, Procedure, Precautions, and Side …
2024年10月4日 · Bacillus Calmette-Guerin (BCG) is an immunotherapy derived from bacteria used to treat some kinds of bladder cancer. The body’s natural response to BCG is thought to help the immune system better respond to cancer cells. It is given as an intravesical therapy, inserted through a catheter to reach the interior of the bladder.
Intravesical immunotherapy (BCG) - Cancer Council NSW
Discover how immunotherapy can prevent bladder cancer recurrence and invasion. Learn about the effectiveness of BCG and TURBT treatment.
Intravesical Therapy for Bladder Cancer | BCAN
2022年2月18日 · An intravesical immunotherapy that causes an immune or allergic reaction that has been shown to kill cancer cells on the lining of the bladder. BCG is often preferred for patients who have high-grade tumors or who have CIS or T1 disease.